Table 1.
Research Design
Groups (G) | Function groups | Injections of Cell–Microsphere Beads in Collagen I gel |
Doses of growth factors/injection | Number of Grafts/ Number of Animals |
---|---|---|---|---|
G1 | Control 1 | Cell-free/empty beads | 0 | 8/2 |
G2 | Control 2 | Human Myoblasts/empty beads | 0 | 8/2 |
G3 | Control 3 | USCs/empty beads | 0 | 8/2 |
G4 | Control 4 | USCs-EC/empty beads | 0 | 8/2 |
G5 | Control 5 | Cell-free combine with IGF/NGF/FGF-1+VEGF+PDGF/HGF beads | IGF (43.75ng), NGF(7.8 ng), FGF-1(15.625ng), VEGF (21.875 ng), PDGF-BB (12.5ng), HGF (62.5ng) | 8/2 |
G6 | Myogenic | USCs combine with PDGF-BB/HGF beads | PDGF-BB (37.5ng), HGF (187.5ng) | 8/2 |
G7 | Angiogenic | USCs combine with VEGF beads | VEGF (65.6 ng) | 8/2 |
G8 | Neurogenic | USCs combine with IGF/NGF/FGF-1 beads | IGF (131.25ng), NGF(23.44 ng), FGF-1(46.875ng) | 8/2 |
G9 | Synergetic 1 | USCs combine with IGF/NGF/FGF-1 + VEGF + PDGF/HGF beads | IGF (43.75ng), NGF(7.8 ng), FGF-1(15.625ng), VEGF (21.875 ng), PDGF-BB (12.5ng), HGF (62.5ng) | 16/4 |
G10 | Synergetic 2 | USCs-ECs combine with IGF/NGF/FGF-1 + VEGF+ PDGF/HGF beads | IGF (43.75ng), NGF(7.8 ng), FGF-1(15.625ng), VEGF (21.875 ng), PDGF-BB (12.5ng), HGF (62.5ng) | 16/4 |